Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Horizon Pharma acquires worldwide rights to BI's interferon gamma-1b

Executive Summary

Horizon Pharma PLC received worldwide rights to Boehringer Ingelheim GmbH's interferon gamma-1b product (trade names Imuki, Imukine, Immukin, Immukine and Actimmune; Horizon already owns rights to the product as Actimmune in US, Canada and Japan). Under the agreement the two parties will also enter into a global supply agreement.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Alliance
    • R&D and Marketing (Licensing)

Related Companies